Monographie - Epirubicin hydrochloride

Última actualização :
08/05/2024

Epirubicin hydrochloride

Estrutura química

Nomes comerciais nos diversos países

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Anthracine	Malásia
Axirubicine	Alemanha
Bendaepi	Alemanha
Binarin	México
Bioepycina	Polonia
Crisabon	Argentina
Cuatroepi	Argentina
Ecclepia	Romènia
Elebicin	México
Ellence	Estados Unidos de América
Epi Cell	Alemanha
Epidoxo	Argentina, Chilli, Venezuela
Epifil	Equator
Epilem	Colômbia, México
Epimedac	Alemanha
Epirubicin	Arábia Saudita, Australia, Austria, Bélgica, Dinamarca, Gran-bretanha, Hungria, Islandia, Nova Zelândia, Suècia, Suicia, Turquia
Epirubicina	Argentina, Colômbia, Equator, Espanha, México, Romènia
Epirubicine	Bélgica, França, Suicia
Farmarubicin	Turquia
Farmorubicin	Arábia Saudita, Austria, Brasil, Dinamarca, Finlandia, Grècia, Noruega, Suècia, Suicia
Farmorubicin CSV	Africa do sul
Farmorubicin PFS	Croácia, Eslovenia, Polonia
Farmorubicin RD	Brasil, Polonia, Russo, Suicia
Farmorubicin RTU	Países Baixos
Farmorubicina	Brasil, Espanha, Itália, Portugal
Farmorubicine	Bélgica, França
Pharmorubicin	Gran-bretanha

Bibliografía : Epirubicin hydrochloride

	Tipo	Publicação
148	Jornal	Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525	Jornal	De Vroe C, De Muynck C, Remon JP, Samsom M. A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. Int J Pharm 1990 ; 65: 49-56.
683	Jornal	Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 1990 ; 43: 265-272.
686	Jornal	Wood MJ, Irwin WJ, Scott DK. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther 1990 ; 15: 279-289.
887	Jornal	Pujol M, Munoz M, Prat J, Giona V, De Bolos J. Stability study of epirubicin in NaCl 0.9% injection. Ann Pharmacotherapy 1997 ; 31: 992-995.
1237	Jornal	Keusters L, Stolk LML, Umans R, Van Asten P. Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation. Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265	Jornal	Wood MJ, Irwin WJ, Scott DK. Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. J Clin Pharm Ther 1990 ; 15: 291-300.
1317	Jornal	Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J 1987 ; 238: 476-478.
1662	Jornal	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1823	Jornal	Sewell GJ, Rigby-Jones AE, Priston MJ. Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 2003 ; 28: 349-353.
1897	Jornal	Sautou-Miranda V, Brigas F, Thibault M, Chopineau J. Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. EJHP 2001 ; 7, 3: 108-115.
1955	Jornal	Trissel LA, Zhang Y. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Ann Pharmacotherapy 2005 ; 39: 280-283.
2168	Jornal	Ozdemir FA, Anilanmert B, Pekin M. Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257	Laboratório	Stability of epirubicin "Ebewe" infusion solutions. Ebewe Pharma 2007
3473	Jornal	Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Int J Pharm 2015 ; 495, 2: 956-962.
3474	Laboratório	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3632	Laboratório	Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics Hospira 2017
3670	Jornal	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3708	Poster	Sarakbi I, Thiesen J, Krämer I. Compatibility of epirubicin-loaded DC Beads with different contrast media. ECOP 2 Krakow 2014
3918	Jornal	Sarakbi I, Krämer I. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. J Oncol Pharm Practice 2016 ; 22: 749-756.
4352	Jornal	Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. J Clin Pharm Ther 2019 ; 44: 875-882.

Mentions Légales